BRAVO PHARMACEUTICALS AS - 14159974 | ScoreStorybook | Print Summary Report
STORYBOOK OÜ Tähe 129b, Tartu, 50113 ESTONIA (+372)7446645 info@scorestorybook.ee ssb.ee
[mo_oauth_login]

BRAVO PHARMACEUTICALS AS

Summary report

Date of report 24.02.2025

BRAVO PHARMACEUTICALS AS
14159974 - Registered
Founded in 29.11.2016
Fixed capital 163,137 €

Former names

  • Bravo Pharmaceuticals OÜ
VAT  
EE101938974 (start 12.01.2017)
start end
12.01.2017 -

Add BRAVO PHARMACEUTICALS AS data to your system

download JSON download CSV

Add BRAVO PHARMACEUTICALS AS data to your information system with one click or download a CSV file. The data is enriched with direct links to Storybook reports. See also the list of machine-readable data.

Don't have CRM? Read more

keywords

  • muud tervishoiuteenused

BRAVO PHARMACEUTICALS AS

Scores and ratings

Reputation score

What is Reputation score?

Credit Score

Risky 0.99

Loader

What is Credit Score?

Open the reports you want to print

Employees and salaries

BRAVO PHARMACEUTICALS AS

Number of employees and estimated average salaries
?

BRAVO PHARMACEUTICALS AS

Employee taxes and performance analysis
?
QuarterLabor taxes
paid		Number of employees
Turnover
Per Employee		Profit
per employee
2024 IV........................
2024 III........................
2024 II........................
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................
2017 I........................
2016 IV........................

Deciders and beneficiaries

BRAVO PHARMACEUTICALS AS

Decision-makers
?

Rakesh Pandey

Relations: 3
Turnover 2024: 56 555 €
Employees: 1
Rakesh Pandey
★★★★

......

Related companies scores

Credit Score: Borderline

Reputation score: 7630

Date of birth: ......

Active relations 3

Other health servicesBusiness advice

Reena Singh

Relations: 1
Turnover 2024: 26 237 €
Employees: 1
Reena Singh
★★★★

......

Related companies scores

Credit Score: Risky

Reputation score: 3240

Date of birth: ......

Active relations 1

Other health services
*

BRAVO PHARMACEUTICALS AS

History of right of representation
?
Field
Health Care
Business age
8y
Beneficial country:
India
 
Reena Singh ... - ...
Rakesh Pandey ... - ...
2016
2017
2019
2020
2021
2022
2024
2025
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025

BRAVO PHARMACEUTICALS AS

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
0.54
..................
79%
!
..................
20%

Former owners

NameCredit ScorePaymentBeginningEnding
!
..................
0.54
..................
0.54
..................
!
..................
!
..................
0.54
..................
!
..................
0.54
..................
0.54
..................
0.54
..................

BRAVO PHARMACEUTICALS AS

Other related parties
?

Former other persons

NameCredit ScorePartBeginning
!
............
0.01
............
!
............
0.01
............
!
............

Other related parties (invalid relations)

NameCredit ScorePartBeginningEnding
0.31
..................
0.99
..................
!
..................

BRAVO PHARMACEUTICALS AS

Subsidiaries and associates
?

Former subsidiaries and associates

NameCredit ScorePaymentBeginningTypeHolding
0.01
..................
65%

Former subsidiaries and associates

NameCredit ScorePaymentBeginningEnding
0.01
..................
0.01
..................
0.01
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

BRAVO PHARMACEUTICALS AS

Goodwill

BRAVO PHARMACEUTICALS AS

Taxes paid and estimated average salaries

BRAVO PHARMACEUTICALS AS

Quarterly indicators
QuarterTurnoverTaxed turnoverLabour productivityLabour productivityEmployeesNational taxesLabor taxes
2024 IV* ............* ..............................
2024 III* ............* ..............................
2024 II* ............* ..............................
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................
2017 I* ............* ..............................

BRAVO PHARMACEUTICALS AS

Sales revenue by business area

BRAVO PHARMACEUTICALS AS

Sales revenue by country

BRAVO PHARMACEUTICALS AS

Financial indicators and prognosis

BRAVO PHARMACEUTICALS AS

Financial raiting: "POOR" (2024 prognosis)
2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

BRAVO PHARMACEUTICALS AS

Real estate as of 24.02.2025

Active and unactive real estate

igon V......

BRAVO PHARMACEUTICALS AS

Annual reports
Year Period Submitted Report PDF
2023 01.01.2023–31.12.2023 08.07.2024 ......
2022 01.01.2022–31.12.2022 26.09.2023 ......
2021 01.01.2021–31.12.2021 21.06.2022 ......
2020 01.01.2020–31.12.2020 12.10.2021 ......
2019 01.01.2019–31.12.2019 21.09.2021 ......
2018 01.01.2018–31.12.2018 09.06.2020 ......
2017 01.01.2017–31.12.2017 12.08.2019 ......

Liabilities and debts

BRAVO PHARMACEUTICALS AS

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

BRAVO PHARMACEUTICALS AS

Reports and assets-liabilities overview 24.02.2025
?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

BRAVO PHARMACEUTICALS AS

Claims history
?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Private debt ...... €

Total debt claims: ...... €

PAYMENT SCHEDULE
......
Latest events
...... ......

BRAVO PHARMACEUTICALS AS

Debt by type 23.02.2025
?
Debt by type
Type of claim Amount of claims In repayment schedule Disputed Management board during which the debt was incurred Representative
Tax collector 's claims ...... € ...... € ...... €
Special income tax ...... € ...... € ...... € ETCB
Unemployment insurance tax ...... € ...... € ...... € ETCB
Social tax ...... € ...... € ...... € ETCB
Value added tax ...... € ...... € ...... € ETCB
Withholding tax ...... € ...... € ...... € ETCB
Creditors' claims ...... € ...... € ...... €
Total ...... € ...... € ...... €

BRAVO PHARMACEUTICALS AS

Time-barred and ongoing claims as of 23.02.2025
?
Ongoing
Sum:
......
...... €
Time-barred
Sum:
......
...... €

BRAVO PHARMACEUTICALS AS

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2024 IV* ...... €...... €...... €...... €......
2024 III* ...... €...... €...... €...... €......
2024 II* ...... €...... €...... €...... €......
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......
2017 I* ...... €...... €...... €...... €......

BRAVO PHARMACEUTICALS AS

Bailiff's enforcement proceedings as of 24.02.2025
?

Bailiff's enforcement proceedings MISSING

BRAVO PHARMACEUTICALS AS

Regulations of the Payment Order Department as of 24.02.2025
?

Regulations of the Payment Order Department MISSING

BRAVO PHARMACEUTICALS AS

Court orders in the register as of 24.02.2025
?
Logo

Puuduste kõrvaldamise määrus

01.08.2024

Regulation number: Ä 50042263 / M3

Regulation status has entered into force: 01.08.2024

Regulation status: Allkirjastatud

Logo

Trahvihoiatusmäärus: majandusaasta aruanne esitamata

07.07.2024

Regulation number: Ä 50042263 / M2

Regulation status has entered into force: 09.07.2024

Date of enforcement of order or additional period: 07.07.2024

Regulation status: Puudused kõrvaldatud

BRAVO PHARMACEUTICALS AS

Decisions of the Consumer Disputes Committee as of 24.02.2025
?

Consumer disputes MISSING

BRAVO PHARMACEUTICALS AS

Court hearings as of 24.02.2025
?

Court hearings MISSING

BRAVO PHARMACEUTICALS AS

Rulings as of 24.02.2025
?

Court settlemets MISSING

BRAVO PHARMACEUTICALS AS

Notices and announcements as of 24.02.2025
?
Logo

Notice of delivery of a Tax and Customs Board document

01.11.2024
Maksu- ja Tolliameti dokumendi kättetoimetamise teade
Avaldamise algus: 01.11.2024
Avaldamise lõpp: 02.02.2025
Maksu- ja Tolliamet avaldab teadaande maksukorralduse seaduse (MKS) § 55 alusel.

Menetlusosalisele AS Bravo Pharmaceuticals (registrikood: 14159974) toimetatakse kätte 22.10.2024 korraldus nr 13-11/61647 maksuvõla tasumiseks summas 1 467,52 eurot kümne päeva jooksul korralduse kättetoimetamisest arvates.

Dokumendi resolutiivosa loetakse kättetoimetatuks kümne päeva möödumisel käesoleva teadaande avaldamisest (MKS § 55).
 
Dokumentide terviktekstidega on võimalik tutvuda Maksu- ja Tolliameti lähimas teenindusbüroos.
Maksu- ja Tolliamet
Tallinn, HARJUMAA, Lõõtsa 8a
Telefon: 8800812
E-post: emta@emta.ee
Teadaande number 2379092
Logo

otice of reduction of share capital

26.09.2024
Aktsiakapitali vähendamise teade
Avaldamise algus: 26.09.2024
Avaldamise lõpp: tähtajatu
AS Bravo Pharmaceuticals (registrikood 14159974) avaldab teadaande äriseadustiku (ÄS) § 358 lõike 2 alusel.

Aktsiaselts teatab aktsiakapitali vähendamise otsusest. Aktsiakapitali vähendatakse aktsiate tühistamise teel 172 200 euro võrra. Uueks aktsiakapitali suuruseks on 163 137 eurot.

Võlausaldajatel palume esitada oma nõuded aktsiaseltsile kahe kuu jooksul käesoleva teate avaldamisest (ÄS § 358 lg 2). Nõuded esitada e-posti aadressil rpandey@bppl.co.in

Teadaande avaldaja: juhatuse liige Rakesh Pandey (37712100101)
Ärinimed
AS Bravo Pharmaceuticals, kehtetud ärinimed: Bravo Pharmaceuticals OÜ.
AS Bravo Pharmaceuticals
Haabneeme alevik, Viimsi vald, Harju maakond, Paadi tee 3
Telefon: +372 56121500
E-post: rpandey@bppl.co.in
Teadaande number 2365061
Logo

Notice of delivery of a Tax and Customs Board document

12.06.2024
Maksu- ja Tolliameti dokumendi kättetoimetamise teade
Avaldamise algus: 12.06.2024
Avaldamise lõpp: 13.09.2024
Maksu- ja Tolliamet avaldab teadaande maksukorralduse seaduse (MKS) § 55 alusel.

Menetlusosalisele AS Bravo Pharmaceuticals (registrikood: 14159974) toimetatakse kätte 21.05.2024 korraldus nr 13-11/30970 maksuvõla tasumiseks summas 3 234,22 eurot kümne päeva jooksul korralduse kättetoimetamisest arvates.

Dokumendi resolutiivosa loetakse kättetoimetatuks kümne päeva möödumisel käesoleva teadaande avaldamisest (MKS § 55).
 
Dokumentide terviktekstidega on võimalik tutvuda Maksu- ja Tolliameti lähimas teenindusbüroos.
Maksu- ja Tolliamet
Tallinn, HARJUMAA, Lõõtsa 8a
Telefon: 8800812
E-post: emta@emta.ee
Teadaande number 2268253

Marketing

Business network

BRAVO PHARMACEUTICALS AS

 Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

BRAVO PHARMACEUTICALS AS

 Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.

We value your privacy

We use cookies to improve your browsing experience, provide personalized ads or content, and analyze our traffic. By clicking "allow all", you agree to our use of all cookies.